Treatment

GS-9911 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
This study is testing a new drug, GS-9911, by itself or with an antibody treatment, Zimberelimab, for adults with advanced solid cancers. It's the first time in humans, focusing on safety and finding the right dose.
For: Solid Tumors
United States · Australia · Canada